Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Aug 12, 2026
- Incorporated
- Delaware
- Filings on record
- 83 filings
- On EDGAR
- CIK 2091349
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 2
News 5
Prospectuses and Registrations 5
Ownership 8 of 62
- 4 Insider reported a trade Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 2, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 13, 2026
Other 8 of 9
- EFFECT Notice that a registration became effective May 12, 2026
- CORRESP Reply to SEC staff May 8, 2026
- UPLOAD Comment letter from SEC staff May 6, 2026
- DRS Draft registration statement, submitted confidentially May 1, 2026
- SEC STAFF ACTION Apr 1, 2026
- CERT Exchange certified a listing Apr 1, 2026
- 10-12B/A Amended filing Mar 27, 2026
- 10-12B Mar 3, 2026
Everything here comes from First Tracks Biotherapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.